Digestive & Intestinal Remedies (Pharmacies) - Botswana

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$1.58m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.04%, resulting in a market volume of US$2.12m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$0.58 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Botswana is experiencing steady growth due to changing customer preferences and trends in the market.

Customer preferences: Customers in Botswana are increasingly seeking digestive and intestinal remedies from pharmacies due to the convenience and accessibility they offer. Pharmacies provide a wide range of over-the-counter medications for digestive issues such as indigestion, heartburn, and constipation. Customers prefer to purchase these remedies from pharmacies as they can receive professional advice from pharmacists and trust the quality of the products. Additionally, pharmacies often offer discounts and promotions on digestive and intestinal remedies, attracting price-conscious customers.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in Botswana is the increasing demand for natural and herbal remedies. Customers are becoming more health-conscious and are seeking alternative solutions to traditional medications. Botswana has a rich biodiversity, and customers are exploring the use of indigenous plants and herbs for digestive health. This trend is driving the growth of natural and herbal remedies in the market. Another trend in the market is the rising awareness of the importance of gut health. Customers are becoming more knowledgeable about the link between gut health and overall well-being. As a result, they are actively seeking products that promote a healthy digestive system. This trend is driving the demand for probiotics and prebiotics, which are known to support gut health.

Local special circumstances: Botswana has a growing middle-class population, which has led to increased disposable income and higher spending on healthcare products. As a result, customers are willing to invest in digestive and intestinal remedies to improve their quality of life. The government of Botswana has also taken initiatives to improve healthcare infrastructure, including the expansion of pharmacies in rural areas. This has made digestive and intestinal remedies more accessible to a larger population.

Underlying macroeconomic factors: The steady economic growth in Botswana has contributed to the development of the Digestive & Intestinal Remedies market. The country has a stable political environment and a well-regulated healthcare sector, which has attracted foreign investment. The government has also implemented policies to promote the pharmaceutical industry, leading to increased production and availability of digestive and intestinal remedies in the market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Botswana is growing due to changing customer preferences, including the demand for natural and herbal remedies and the focus on gut health. The growing middle-class population, improved healthcare infrastructure, and stable macroeconomic factors have also contributed to the market's development.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.